IMR Press / EJGO / Volume 21 / Issue 4 / pii/2000206

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Open Access Original Research

The long term results of radiotherapy with or without surgery in management of advanced vulvar cancer: Report of 76 patients

Show Less
1 Assoc. Professor, University of Gaziantep, Sabinbey Medical Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Gazianep, Turkey
2 Professor of Gynecologic Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
3 Assist. Professor of Gynecologic Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
4 Professor of Radiotherapy, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Eur. J. Gynaecol. Oncol. 2000, 21(4), 426–429;
Published: 10 August 2000
Abstract

Background: The combination of conservative surgery plus radiotherapy for vulvar cancer has been well established as a thera­peutic alternative to extensive radical surgery. This study was undertaken to evaluate the long-term results of radiotherapy with or without surgery in the management of advanced vulvar cancer. Patients and Methods: The cases of 76 patients who had advanced carcinoma of the vulva treated with different modalities at the University of Texas M.D. Anderson Cancer Center were retrospectively reviewed. Three patients had unstaged disease as a result of previous surgery, 19 had stage II, 40 had stage III, and 14 had stage IV disease. Follow-up ranged from 4 to 17 years (median, 11 years). Results: Five-year disease-free survivals were 75, 67, 68 and 52% for treatment groups I, II, III, and IV, respectively. Disease was controlled locally in 83, 80, 73 and 56% of patients in groups I through IV, respectively; the overall rate of local control was 79%. There was no significant difference in primary tumor control, 5-year disease-free survival, or overall survival among the different treatment groups (p = 0.1300). However, these rates did differ significantly (p < 0.006) based on FIGO stage of disease. Conclusion: In this report, the cure of vulvar cancers with radiotherapy alone (5-year disease-free survival 52% and local control 56%), the radiotherapeutic salvage of patients with surgical failure and/or large tumors, the improved survival with low morbidity by pre- and postoperative radiotherapy were provocative observations suggesting the value of this therapy for advanced vulvar cancer.

Keywords
Vulvar cancer
Radiotherapy
Wide local excision
Radical vulvectomy
Share
Back to top